Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Sales | 2,538 | 4,320 | 4,316 | 0 |
| Cost of Goods | 2,472 | 3,366 | 2,778 | N/A |
| Gross Profit | 66 | 954 | 1,538 | N/A |
| Operating Expenses | 11,725 | 8,187 | 2,513 | 0 |
| Operating Income | -11,187 | -6,867 | -197 | N/A |
| Interest Expense | 141 | 1,023 | 1,963 | 0 |
| Pre-tax Income | -11,328 | -7,890 | -2,160 | 0 |
| Net Income Continuous | -11,328 | -7,890 | -2,160 | N/A |
| Net Income | $-11,328 | $-7,890 | $-2,160 | $N/A |
| EPS Basic Total Ops | -315.14 | -786.71 | -2,749.00 | N/A |
| EPS Basic Continuous Ops | -315.09 | -786.12 | -2,427.57 | N/A |
| EPS Diluted Total Ops | -315.14 | -786.71 | -2,749.00 | N/A |
| EPS Diluted Continuous Ops | -315.09 | -786.12 | -2,427.57 | N/A |
| EBITDA(a) | $-11,003 | $-6,723 | $-49 | $N/A |